Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence

Vaccine

Volumn 24, Issue 2, 2006, Pages 195-205

  Costa, Simone M ^a   Paes, Marciano V ^a   Barreto, Débora F ^a   Pinhão, Angela T ^a   Barth, Ortrud M ^a   Queiroz, João L S ^a   Armôa, Geraldo R G ^a   Freire, Marcos S ^a   Alves, Ada M B ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Dengue virus; DNA vaccine; NS1

Indexed keywords

DNA VACCINE; EPITOPE; NON STRUCTURAL 1 PROTEIN; PLASMID DNA; RECOMBINANT PROTEIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY DEPENDENT ENHANCEMENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; DENGUE; DIMERIZATION; EUKARYOTIC CELL; GENE FUSION; GENETIC CODE; INFECTION PREVENTION; INOCULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECRETION; PROVOCATION TEST; SIGNAL TRANSDUCTION; VIRUS GENE; VIRUS INDUCTION;

ANIMALS; ANTIBODIES, VIRAL; BASE SEQUENCE; DENGUE VIRUS; DNA PRIMERS; GENE FUSION; MICE; PLASMIDS; TISSUE PLASMINOGEN ACTIVATOR; VACCINES, DNA; VIRAL NONSTRUCTURAL PROTEINS; VIRAL VACCINES;

EID: 28644440159     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.07.059     Document Type: Article

References (42)

1. T.P. Monath, and F.X. Heinz Flaviviruses B.N. Fields D.M. Knipe P.M. Howley Fields virology 1996 Raven Press New York 961 1034
2. J.G. Rigau-Pérez, G.G. Clark, D.J. Gubler, P. Reiter, E.J. Sanders, and A.V. Vorndam Dengue and dengue haemorrhagic fever Lancet 352 1998 971 977
3. S.B. Halstead, and E.J. O'Rourke Dengue viruses and mononuclear phagocytes I. Infection enhancement by non-neutralizing antibody J Exp Med 146 1977 201 229
4. A.L. Rothman, and F.A. Ennis Immunopathogenesis of dengue hemorrhagic fever Virology 257 1999 1 6
5. D.J. Gubler, and D.W. Trent Emergence of epidemic dengue/dengue hemorrhagic fever as a public health problem in the Americas Infect Ag Dis 2 1994 383 393
6. S.E. Roberstson, M.V. Mayans, A. El-Husseiny, J.D. Clemens, and B. Ivanoff The WHO vaccine trial registry Vaccine 20 2002 31 41
7. T.J. Chambers, T.F. Tsai, Y. Pervikov, and T.P. Monath Vaccine development against dengue and Japanese encephalitis: report of a World Health Organization meeting Vaccine 15 1997 1494 1502
8. R. Putnak Progress in the development of recombinant vaccinates against dengue and other arthropod-borne flaviviruses E. Kurstak Modern vaccinology 1994 Plenum Medical New York 231 252
9. J.J. Schlesinger, M.W. Brandriss, and E.E. Walsh Protection of mice against dengue 2 virus encephalitis by immunization with the dengue 2 virus non-structural glycoprotein NS1 J Gen Virol 68 1987 853 857
10. E.A. Henchal, L.S. Henchal, and J.J. Schlesinger Synergistic interactions of anti-NS1 monoclonal antibodies protect passively immunized mice from lethal challenge with dengue 2 virus J Gen Virol 69 1988 2101 2107
11. J.B. Ulmer, J.J. Donnelly, S.E. Parker, G.H. Rhodes, P.L. Felgner, and V.J. Dwarki Heterologous protection against influenza by injection of DNA encoding a viral protein Science 259 1993 1745 1749
12. J.J. Donnelly, J.B. Ulmer, J.W. Shiver, and M.A. Liu DNA vaccines Ann Rev Immunol 15 1997 617 648
13. G. Colombage, R. Hall, M. Pavy, and M. Lobigs DNA-based and alphavirus-vectored immunisation with PrM and E proteins elicits long-lived and protective immunity against the flavivirus, murray valley encephalitis virus Virology 250 1998 151 163
14. J. Schultz, G. Dollenmaier, and K. Mölling Update on antiviral DNA vaccine research (1998-2000) Intervirology 43 2000 197 217
15. E. Konishi, M. Yamaoka, I. Kurane, and P.W. Mason A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice Vaccine 18 2000 1133 1139
16. T.J. Kochel, K. Raviprakash, C.G. Hayes, D.M. Watts, K.L. Russell, and A.S. Gonzalo A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys Vaccine 18 2000 3166 3173
17. G.J.J. Chang, B.S. Davis, A.R. Hunt, D.A. Holmes, and G. Kuno Flavivirus DNA vaccines: current status and potential Ann N Y Acad Sci 951 2002 272 285
18. R. Putnak, J. Fuller, L. VanderZanden, B.L. Innis, and D.W. Vaughn Vaccination of rhesus macaques against dengue-2 virus with a plasmid DNA vaccine encoding the viral pre-membrane and envelope genes Am J Trop Med Hyg 68 2003 469 476
19. R.M.R. Nogueira, M.P. Miagostovich, E. Lampe, R.W. Souza, S.M.O. Zagne, and H.G. Schatzmayr Dengue epidemic in the state of Rio de Janeiro, Brazil, 1990-1: co-circulation of dengue 1 and dengue 2 serotypes Epidemiol Infect 111 1993 163 170
20. J. Sambrook, E.F. Fritsch, and T. Maniatis Molecular cloning: a laboratory manual 1989 Cold Spring Harbor Laboratory Press New York
21. I. Schneider Cell lines derived from late embryonic stages of Drosophila melanogaster J Embryol Exp Morphol 27 1972 353 365
22. E.M. Lemes, M.P. Miagostovicsh, A.M. Alves, S.M. Costa, A.M. Fillipis, G.R. Armoa, and M.A. Araujo Circulating human antibodies against dengue NS1 protein: potential of recombinant D2V-NS1 proteins in diagnostic tests J Clin Virol 32 2005 305 312
23. E. Reynolds The use of lead citrate at high pH as an electron-opaque stain in electron microscopy J Cell Biol 17 1963 208 212
24. P.S. Caufour, M.C.A. Motta, A.M.Y. Yamamura, S. Vazques, I.I. Ferreira, and A.V. Jabor Construction, characterization and immunogenicity of recombinant yellow fever 17D-dengue type 2 viruses Virus Res 79 2001 1 14
25. W. Erhardt, A. Hebestedt, G. Aschenbrenner, B. Pichotka, and G. Blumel A comparative study with various anesthetics in mice (pentobarbitone, ketamine-xylazine, carfentanyl-etomidate) Res Exp Med (Berl) 184 1984 159 169
26. M.J. Pryor, and P.J. Wright The effects of site-directed mutagenesis on the dimerization and secretion of the NS1 protein specified by dengue virus Virology 194 1993 769 780
27. M.J. Pryor, and P.J. Wright Glycosylation mutants of dengue virus NS1 protein J Gen Virol 75 1994 1183 1187
28. M. Flamand, F. Megret, M. Mathieu, J. Lepault, F.A. Rey, and V. Deubel Dengue virus type 1 nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble examer in a glycosylation-dependent fashion J Virol 73 1999 6104 6110
29. J.S. Boyle, C. Koniaras, and A.M. Lew Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization Int Immunol 9 1997 1897 1906
30. G. Inchauspe, L. Vitvitski, M.E. Major, G. Jung, U. Spengler, M. Maisonnas, and C. Trepo Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization DNA Cell Biol 16 1997 185 195
31. H.L. Davis, M. Mancini, M.L. Michel, and R.G. Whalen DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost Vaccine 14 1996 910 915
32. R.R. Deck, C.M. DeWitt, J.J. Donnelly, M.A. Liu, and J.B. Ulmer Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine Vaccine 15 1997 71 78
33. A.M.B. Alves, M.O. Lásaro, A.S. Pyrrho, C.R. Gattass, D.F. Almeida, and L.C.S. Ferreira Antibody response in mice immunized with plasmid DNA encoding the colonization factor antigen I (CFA/I) of enterotoxigenic Escherichia coli (ETEC) FEMS Immunol Med Microbiol 23 1999 321 330
34. J. An, J. Kimura-Kuroda, Y. Hirabayashi, and K. Yasui Development of a novel mouse model for dengue virus infection Virology 263 1999 70 77
35. M.V. Paes, A.T. Pinhão, D.F. Barreto, S.M. Costa, M.P. Oliveira, and A.C. Nogueira Liver injury and viremia in mice infected with Dengue-2 virus Virology 338 2005 236 246
36. Y. Sato, M. Roman, H. Tighe, D. Lee, M. Corr, and M.D. Nguyen Immunostimulatory DNA sequences necessary for effective intradermal gene immunization Science 273 1996 352 354
37. A.A. Horner, S.K. Datta, K. Takabayashi, I.M. Belyakov, T. Hayashi, and N. Cinman Immunostimulatory DNA-based vaccines elicit multifaceted immune responses against HIV at systemic and mucosal sites J Immunol 167 2001 1584 1591
38. S.F. Wu, C.L. Liao, Y.L. Lin, C.T. Yeh, L.K. Chen, and Y.F. Huang Evaluation of protective efficacy and immune mechanisms of using a non-structural protein NS1 in DNA vaccine against dengue 2 virus in mice Vaccine 21 2003 3919 3929
39. Z. Li, A. Howard, C. Kelley, G. Delogu, F. Collins, and S. Morris Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences Infect Immun 67 9 1999 4780 4786
40. A.M. Alves, M.O. Lasaro, D.F. Almeida, and L.C. Ferreira DNA immunisation against the CFA/I fimbriae of enterotoxigenic Escherichia coli (ETEC) Vaccine 19 2001 788 795
41. M.S. Ashok, and P.N. Rangarajan Protective efficacy of a plasmid DNA encoding Japanese encephalitis virus envelope protein fused to tissue plasminogen activator signal sequences: studies in a murine intracerebral virus challenge model Vaccine 20 2002 1563 1570
42. A.K. Srivastava, Putm, J.R. Putnak, R.L. Warren, and C.H. Hoke Jr. Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection Vaccine 13 1995 1251 1258